Current induction therapy strategies and anti-t lymphocyte globulin usage in kidney transplantation: consensus-based recommendations by a Turkish expert panel

Basit Öğe Kaydı
dc.authorscopusidAyhan Dinçkan / 8656794300
dc.authorwosidAyhan Dinçkan / AAO-2633-2020
dc.contributor.authorÇakır, Ülkem
dc.contributor.authorDinçkan, Ayhan
dc.contributor.authorKaradoğan, Nayim
dc.contributor.authorKeven, Kenan
dc.contributor.authorKoçak, Hüseyin
dc.contributor.authorKoç, Serkan Kubilay
dc.contributor.authorSezer, Siren
dc.contributor.authorTöz, Hüseyin
dc.contributor.authorUsalan, Celalettin
dc.contributor.authorYıldız, Alaattin
dc.date.accessioned2025-04-18T08:45:22Z
dc.date.available2025-04-18T08:45:22Z
dc.date.issued2024
dc.departmentİstinye Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü
dc.description.abstractThis advisory committee convened to review national and global kidney transplantation dynamics and provide recom-mendations on the use of anti-T lymphocyte globulin (ATLG) for prevention and treatment of rejection after allogeneic kidney transplantation. A critical evaluation of 6 relevant articles released up to October 2022 was performed to reveal their importance in clinical practice. Additionally, 27 key questions on the indication, dosage of ATLG, and risk stratification were used for the Delphi technique with 8 members of the Turkish Society of Nephrology including 5 kidney transplanta-tion (KTx) subcommittee members and a surgeon experienced in solid organ transplantation. The committee declared that T & uuml;rkiye had great potential in KTx; however, increase in transplantation would be possible in the case of raise in the deceased donor transplantation. As a consensus, ATLG was strongly recommended for induction and rejection treatment. Also, committee members recommended the safe dosage range in steroid resistant acute rejection as 2.5-3 mg/kg daily for 5-7 days, and the median of preferred dosage in induction sounded as 2-2.5 mg/kg daily for 3 days in intermediate risk state. Additionally, post-transplant infection and malignancy cases due to immunosuppression were much rarely encoun-tered than they were in the past
dc.identifier.citationÇakır, Ü., Dinçkan, A., Karadoğan, N., Keven, K., Koçak, H., Koç, S. K., ... & Yıldız12, A. (2024). Current Induction Therapy Strategies and Anti-T Lymphocyte Globulin Usage in Kidney Transplantation: Consensus-Based Recommendations by a Turkish Expert Panel. Turkish Journal of Nephrology, 33(2).
dc.identifier.doi10.5152/turkjnephrol.2024.23684
dc.identifier.endpage152
dc.identifier.issn2667-4440
dc.identifier.issue2
dc.identifier.scopus2-s2.0-85192288645
dc.identifier.scopusqualityQ4
dc.identifier.startpage145
dc.identifier.urihttp://dx.doi.org/10.5152/turkjnephrol.2024.23684
dc.identifier.urihttps://hdl.handle.net/20.500.12713/6604
dc.identifier.volume33
dc.identifier.wosWOS:001236262600003
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.institutionauthorDinçkan, Ayhan
dc.institutionauthoridAyhan Dinçkan / 0000-0003-1395-333X
dc.language.isoen
dc.publisherAves
dc.relation.ispartofTurkish journal of nephrology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAnti-T-Lymphocyte Globulin
dc.subjectİnduction Therapy
dc.subjectRenal Transplantation
dc.titleCurrent induction therapy strategies and anti-t lymphocyte globulin usage in kidney transplantation: consensus-based recommendations by a Turkish expert panel
dc.typeArticle

Dosyalar

Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.17 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Cerrahi Tıp Bilimleri Bölümü Makale Koleksiyonu